"Dr Liknaitzky has beenengaged to advise on the research of novel psychiatric agents and associated therapies that are potentiallysuitable for use in the treatment of anxiety and depression-related illnesses. Incannex expects to provide anupdate on Dr Liknaitzky’s appointment to shareholders soon."
only a matter of time...
